| Title : Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease - Hock_2000_Ann.N.Y.Acad.Sci_920_285 |
| Author(s) : Hock C , Maddalena A , Heuser I , Naber D , Oertel W , von der Kammer H , Wienrich M , Raschig A , Deng M , Growdon JH , Nitsch RM |
| Ref : Annals of the New York Academy of Sciences , 920 :285 , 2000 |
| Abstract : Hock_2000_Ann.N.Y.Acad.Sci_920_285 |
| ESTHER : Hock_2000_Ann.N.Y.Acad.Sci_920_285 |
| PubMedSearch : Hock_2000_Ann.N.Y.Acad.Sci_920_285 |
| PubMedID: 11193166 |